The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Gallium Disrupts Iron Metabolism of Mycobacteria Residing within Human Macrophages
Open accessAbstract
Mycobacterium tuberculosis and M. avium complex (MAC) enter and multiply within monocytes and macrophages in phagosomes. In vitro growth studies using standard culture media indicate that siderophore-mediated iron (Fe) acquisition plays a critical role in the growth and metabolism of both M. tuberculosis and MAC. However, the applicability of such studies to conditions within the macrophage phagosome is unclear, due in part to the absence of experimental means to inhibit such a process. Based on the ability of gallium (Ga 3+) to concentrate within mononuclear phagocytes and on evidence that Ga disrupts cellular Fe-dependent metabolic pathways by substituting for Fe 3+and failing to undergo redox cycling, we hypothesized that Ga could disrupt Fe acquisition and Fe-dependent metabolic pathways of mycobacteria. We find that Ga(NO 3)3 and Ga-transferrin produce an Fe-reversible concentration-dependent growth inhibition of M. tuberculosis strains and MAC grown extracellularly and within human macrophages. Ga is bactericidal for M. tuberculosis growing extracellularly and within macrophages. Finally, we provide evidence that exogenously added Fe is acquired by intraphagosomal M. tuberculosis and that Ga inhibits this Fe acquisition. Thus, Ga(NO 3)3 disruption of mycobacterial Fe metabolism may serve as an experimental means to study the mechanism of Fe acquisition by intracellular mycobacteria and the role of Fe in intracellular survival. Furthermore, given the inability of biological systems to discriminate between Ga and Fe, this approach could have broad applicability to the study of Fe metabolism of other intracellular pathogens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inside the macrophage, Mtb disrupts phagolysosomal maturation, an iron-dependent process critical for pathogen survival (Olakanmi et al., 2000).”
From Iron in infection and immunity (2013) · cites this paper as Olakanmi et al., 2000
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Byrd, T. F., & Horwitz, M. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114038 · Cited by 320
Role of Iron in Nramp1-Mediated Inhibition of Mycobacterial Growth
Zwilling, B. S., Kuhn, D. E., Wikoff, L., Brown, D., & Lafuse, W. (1999) · Infection and Immunity · doi:10.1128/iai.67.3.1386-1392.1999 · Cited by 155
Acquisition of iron from transferrin and lactoferrin by the protozoan Leishmania chagasi
Wilson, M. E., Vorhies, R. W., Andersen, K. A., & Britigan, B. E. (1994) · Infection and Immunity · doi:10.1128/iai.62.8.3262-3269.1994 · Cited by 79
Self-citation
Research works printed but not linked: 53
- Barclay R. Ratledge C. Participation of iron in the growth inhibition of pathogenic strains of Mycobacterium avium and M. paratuberculosis in serum.Zentbl. Bakteriol. Hyg. A2621986189194
- Bernstein L. R. Mechanisms of therapeutic activity for gallium.Pharmacol. Rev.501998665682
- Bullen J. J. Rogers H. J. Griffiths E. Role of iron in bacterial infection.Curr. Top. Microbiol. Immunol.801978135
- Byrd T. F. Horwitz M. A. Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila.J. Clin. Investig.88199111031112 · DOI
- 10.1159/000203952 · DOI
- 10.1006/mpat.1997.9999 · DOI
- 10.1182/blood.V72.6.1930.1930 · DOI
- Chitambar C. R. Zivkovic Z. Uptake of gallium-67 by human leukemic cells: demonstration of transferrin receptor-dependent and transferrin-independent mechanisms.Cancer Res.47198739293934
- 10.1084/jem.184.4.1349 · DOI
- 10.1093/clinids/24.Supplement_1.S121 · DOI · Paper page
- 10.1084/jem.178.6.2243 · DOI
- 10.1128/JB.181.15.4443-4451.1999 · DOI
- 10.1128/iai.50.1.1-8.1985 · DOI
- 10.1099/13500872-142-6-1521 · DOI
- 10.1046/j.1365-2958.1996.1461511.x · DOI
- 10.1046/j.1432-1327.1998.2580485.x · DOI
- 10.1021/bi00364a026 · DOI
- Emery T. Hoffer P. B. Siderophore-mediated gallium uptake demonstrated in the microorganism Ustilago sphaerogenea.J. Nucl. Med.211980935939
- 10.1093/clinids/5.Supplement_4.S759 · DOI
- 10.1084/jem.178.6.2249 · DOI
- Foster B. J. Clagett-Carr K. Hoth D. Leyland-Jones B. Gallium nitrate: the second metal with clinical activity.Cancer Treatment Rep.70198613111319
- Gaynor C. D. McCormack F. X. Voelker D. R. McGowan S. E. Schlesinger L. S. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages.J. Immunol.155199553435351 · DOI
- 10.1084/jem.183.4.1527 · DOI
- 10.1073/pnas.92.11.5189 · DOI
- Hall R. M. Sritharan M. Messenger A. J. M. Ratledge C. Iron transport in Mycobacteria smegmatis: occurrence of iron-regulated envelope proteins as potential receptors for iron uptake.J. Gen. Microbiol.133198721072114
- 10.1007/BF00690163 · DOI
- 10.1056/NEJM199612263352604 · DOI
- 10.1086/515549 · DOI · Paper page
- 10.1128/IAI.66.6.2769-2777.1998 · DOI
- 10.1002/1097-0142(19801101)46:9<2009::AID-CNCR2820460919>3.0.CO;2-A · DOI
- 10.1002/1097-0142(197911)44:5<1722::AID-CNCR2820440528>3.0.CO;2-C · DOI
- Mann G. J. Musgrove E. A. Fox R. M. Thelander L. Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation.Cancer Res.48198851515156
- 10.1093/clinchem/38.9.1883 · DOI
- Menon S. Wagner H. N. Jr. Tsan M.-F. Studies on gallium accumulation in inflammatory lesions: II uptake by staphylococcus aureus: concise communication.J. Nucl. Med.1919784447
- 10.1128/CMR.8.4.496 · DOI
- 10.1128/AAC.39.8.1824 · DOI
- 10.1056/NEJM199612263352602 · DOI
- 10.1146/annurev.bi.50.070181.003435 · DOI
- Olakanmi O. Stokes J. B. Britigan B. E. Acquisition of iron bound to low molecular weight chelates by human monocyte-derived macrophages.J. Immunol.153199426912703 · DOI
- 10.3109/10408419209114559 · DOI
- 10.1007/BF01247377 · DOI
- 10.1046/j.1523-1755.1999.055Suppl.69002.x · DOI
- 10.1126/science.8511586 · DOI
- Schlesinger L. S. Bellinger-Kawahara C. G. Payne N. R. Horwitz M. A. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.J. Immunol.144199027712780 · DOI
- Schlesinger L. S. Hull S. R. Kaufman T. M. Binding of ther terminal mannosyl units of lipoarabinomannan from a virulent strain of Mycobacterium tuberculosis to human macrophages.J. Immunol.152199440704079 · DOI
- 10.1002/ajh.2830410403 · DOI
- 10.1042/bj3050187 · DOI
- 10.1042/bj1150199 · DOI
- 10.1002/j.1460-2075.1996.tb01088.x · DOI · Paper page
- 10.2165/00003495-199142020-00007 · DOI
- Tsan M.-F. Mechanism of gallium-67 accumulation in inflammatory lesions.J. Nucl. Med.2619868892
- Wheeler P. R. Ratledge C. Metabolism of Mycobacterium tuberculosis Tuberculosis: pathogenesis protection and control. Bloom B. R. 1994 353 388 ASM Press Washington D.C. · DOI
- 10.1128/jb.178.21.6394-6398.1996 · DOI
Cited by
Sorted by citations
Items 101–194 of 194
Gallium(iii) and iron(iii) complexes of quinolone antimicrobials.
Mjos, K. D., Cawthray, J., Polishchuk, E., Abrams, M., & Orvig, C. (2016) · Dalton Transactions · doi:10.1039/c6dt01315e · Cited by 27
Effect of novel antibacterial gallium-carboxymethyl cellulose on Pseudomonas aeruginosa
Valappil, S. P., Yiu, H. H. P., Bouffier, L., Hope, C. K., Evans, G., Claridge, J. B., Higham, S. M., & Rosseinsky, M. J. (2012) · Dalton Transactions · doi:10.1039/c2dt32235h · Cited by 31
Bastos, T. D. O., Soares, B. M., Cisalpino, P., Mendes, I. C., dos Santos, R. G., & Beraldo, H. (2010) · Microbiology Research · doi:10.1016/j.micres.2009.10.005 · Cited by 27
“Gallium presents antimicrobial activity against pathogens responsible for tuberculosis in humans – Mycobacterium tuberculosis and Mycobacterium avium (Olakanmi et al. 2000).”
BackgroundStudy of b-quark mass effects in multijet topologies with the DELPHI detector at LEP
Reinhardtii, C. (2008) · doi:10.1140/epjc/s10052-008-0631-5 · Cited by 27
“metabolism, and the similar ionic radii of Ga3+ to Fe3+ enables Ga3+ to prevent the metabolism by a ‘Trojan Horse’ type mechanism, owing to the fact the Ga3+ does not undergo redox reactions, unlike Fe3+ which is critical for bacterial growth.[163, 167, 171] The most promising method of delivery of antibacterial ions…”
Glutathione-dependent extracellular ferric reductase activities in dimorphic zoopathogenic fungi.
Zarnowski, R., & Woods, J. P. (2005) · Microbiology · doi:10.1099/mic.0.27918-0 · Cited by 27
“Due to their physical/chemical properties they can substitute for Fe in many molecular processes and disrupt them by competitive inhibition (Olakanmi et al., 2000).”
BackgroundGallium-containing phosphosilicate glasses: functionalization and in-vitro bioactivity.
Lusvardi, G., Malavasi, G., Menabue, L., & Shruti, S. (2013) · Materials Science and Engineering C: Materials for Biological Applications · doi:10.1016/j.msec.2013.03.046 · Cited by 26
Treatment and chemoprophylaxis for paratuberculosis.
Fecteau, M., & Whitlock, R. (2011) · The Veterinary clinics of North America. Food animal practice · doi:10.1016/j.cvfa.2011.07.002 · Cited by 25
Understanding the Potential and Risk of Bacterial Siderophores in Cancer
Pita-Grisanti, V., Chasser, K. M., Sobol, T., & Cruz‐Monserrate, Z. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.867271 · Cited by 29
Comella-del-Barrio, P., Abellana, R., Villar-Hernández, R., Coute, M. D. J., Mingels, B. S., Aliaga, L. C., Narcisse, M., Gautier, J., Ascaso, C., Latorre, I., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01855 · Cited by 24
“Iron is an essential cofactor for mycobacteria propagation during infection (Olakanmi et al., 2000), and successful protective host-immune response (Mainou-Fowler and Brock, 1985).”
BackgroundPotential use of gallium-doped phosphate-based glass material for periodontitis treatment
Sahdev, R., Ansari, T., Higham, S., & Valappil, S. (2015) · Journal of Biomaterials Applications · doi:10.1177/0885328215571952 · Cited by 24
“This modification was made to the medium to warrant chealation(30) of any free iron in the medium that might interfere with the antimicrobial effect of gallium.(31) Diluting the TSB medium to 40% of the manufacturer’s recommendations and complementing with hemin (5 lg/mL) and menadione (1 lg/mL) was previously reporte…”
BackgroundThom, R. E., Elmore, M. J., Williams, A., Andrews, S. C., Drobniewski, F., Marsh, P. D., & Tree, J. A. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.03.008 · Cited by 23
Gallium containing calcium phosphates: potential antibacterial agents or fictitious truth.
Mosina, M., Kovrlija, I., Stipniece, L., & Ločs, J. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.07.063 · Cited by 22
Betz, B., Azad, A., Morris, J. D., Rajaram, M. V. S., & Schlesinger, L. (2011) · Microbial Pathogenesis · doi:10.1016/j.micpath.2011.06.006 · Cited by 22
“MDMmonolayers in a 24-well tissue culture plate at Day 5 were repletedwith 20% serum-containing RPMI and incubated for 7more days to ensure stable adherence of cells [36].”
MethodSelf-citationPickup, D., Moss, R., Qiu, D., Newport, R., Valappil, S., Knowles, J. C., & Smith, M. E. (2009) · Journal of Chemical Physics · doi:10.1063/1.3076057 · Cited by 22
Antimicrobial Synergism Toward Pseudomonas aeruginosa by Gallium(III) and Inorganic Nitrite
Zemke, A. C., Madison, C. J., Kasturiarachi, N. S., Pearce, L. L., & Peterson, J. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.02113 · Cited by 22
“, 2006), Mycobacterium tuberculosis (Olakanmi et al., 2000) Acinetobacter baumannii (de Léséleuc et al.”
BackgroundKeenan, T., Placek, L., Hall, M., & Wren, A. (2017) · Journal of Biomedical Materials Research. Part B - Applied biomaterials · doi:10.1002/jbm.b.33655 · Cited by 21
Ghasemi, J. B., & Zolfonoun, E. (2011) · Environmental Monitoring and Assessment · doi:10.1007/s10661-011-2237-x · Cited by 22
“The role of gallium in pharmacokinetics and its toxicity have been investigated thoroughly (Anthemidis et al. 2003; Olakanmi et al. 2000 ).”
BackgroundArnett, E., Pahari, S., Wager, C. M. L., Hernandez, E., Bonifacio, J. R., Lumbreras, M., Renshaw, C. W., Montoya, M., Opferman, J., & Schlesinger, L. S. (2023) · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · doi:10.1016/j.biopha.2023.115738 · Cited by 20
“For CFU assays, infected macrophages and granulomas were lysed as described previously [20,33].”
MethodSelf-citationEffect of Gallium on Growth of Streptococcus mutans NCTC 10449 and Dental Tissues
Valappil, S., Owens, G., Miles, E., Farmer, N., Cooper, L., Miller, G., Clowes, R., Lynch, R., & Higham, S. (2013) · Caries Research · doi:10.1159/000354048 · Cited by 20
“However, unlike Fe 3+ , Ga 3+ is unable to undergo redox cycling; the incorporation of Ga 3+ therefore results in the collapse of cellular processes essential to maintain viability [Olakanmi et al., 2000].”
BackgroundZeng, J., Wu, L.-W., Liu, Z., Lv, Y., Feng, J., Wang, W., Xue, Y.-X., Wang, D., Li, J.-B., Drlica, K., et al. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01595-20 · Cited by 19
“with iron uptake (11, 15, 16), iron metabolism, and catalysis by iron-containing enzymes, because Ga31 is similar to Fe31 in terms of ionic radius, ionization potential, coordination chemistry, electronegativity, and electron affinity (7, 10).”
BackgroundSahoo, P. K., Murthy, P. S., Dhara, S. K., Venugopalan, V. P., Das, A., & Tyagi, A. K. (2013) · Journal of Nanoparticle Research · doi:10.1007/s11051-013-1841-9 · Cited by 18
“and malaria infections (Olakanmi et al. 2000; Yan et al. 1991).”
Multiple ABC transporters are involved in the acquisition of petrobactin in Bacillus anthracis
Dixon, S. D., Janes, B. K., Bourgis, A. E. T., Carlson, P. E., & Hanna, P. C. (2012) · Molecular Microbiology · doi:10.1111/j.1365-2958.2012.08028.x · Cited by 19
“Gallium resistance has been used to show siderophore transport in several bacterial systems (Ecker and Emery, 1983; Olakanmi et al., 2000; Banin et al., 2008; Carlson et al., 2010).”
Fecteau, M., Whitlock, R., Fyock, T., Mcadams, S., Boston, R., & Sweeney, R. (2011) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2011.0768.x · Cited by 19
Chaffin, M., Fajt, V., Martens, R., Arnold, C. E., Cohen, N. D., O'Conor, M., Taylor, R. J., & Bernstein, L. R. (2010) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2009.01150.x · Cited by 19
“avium when the bacteria are located extracellularly or within human monocyte-derived macrophages (Oyebode et al., 2000).”
BackgroundInfluentialEby, G. (2005) · Medical Hypotheses · doi:10.1016/j.mehy.2005.06.021 · Cited by 19
“[11] showed in 2000 that gallium disrupts iron III metabolism of several mycobacterias, including Mycobacterium tuberculosis, within human macrophages.”
BackgroundEvolution of gallium applications in medicine and microbiology: a timeline
de Assis, A. S. J., Pegoraro, G. M., & Duarte, I. (2022) · Biometals · doi:10.1007/s10534-022-00406-4 · Cited by 18
Forging New Antibiotic Combinations under Iron-Limiting Conditions
Chan, D. C. K., Guo, I., & Burrows, L. (2019) · Antimicrobial Agents and Chemotherapy · doi:10.1101/775445 · Cited by 18
Choi, S.-R., Britigan, B., & Narayanasamy, P. (2019) · Msphere · doi:10.1128/msphere.00443-19 · Cited by 18
“Fe-free 7H9 medium was prepared as described previously (11).”
MethodResultSelf-citationNano-antimicrobials: A new paradigm for combating mycobacterial resistance.
Minakshi, P., Ghosh, M., Brar, B., Kumar, R., Lambe, U., Ranjan, K., Prasad, G., & Manoj, J. (2019) · Current pharmaceutical design · doi:10.2174/1381612825666190620094041 · Cited by 18
Inorganic Nanoparticles: Innovative Tools for Antimicrobial Agents
Kurtjak, M., Aničić, N., & Vukomanovicć, M. (2017) · InTech eBooks · doi:10.5772/67904 · Cited by 18
Fecteau, M., Aceto, H., Bernstein, L., & Sweeney, R. (2014) · The Veterinary Journal · doi:10.1016/j.tvjl.2014.06.023 · Cited by 18
“At inflammation sites Ga is taken up by phagocytes, interferes with irondependent cellular pathways, and causes bacterial death (Olakamni et al., 2000).”
BackgroundIron acquisition by Mycobacterium tuberculosis residing within myeloid dendritic cells
Olakanmi, O., Kesavalu, B., Abdalla, M. Y., & Britigan, B. E. (2013) · Microbial Pathogenesis · doi:10.1016/j.micpath.2013.09.002 · Cited by 17
Self-citationSaberyan, K., Zolfonoun, E., Shamsipur, M., & Salavati-Niasari, M. (2009) · doi:10.1080/01496390902775257 · Cited by 17
“The role of gallium in pharmacokinetics and its toxicity have been investigated thoroughly (2,3).”
BackgroundBernstein, L. (2013) · doi:10.1007/978-1-4614-1533-6_113 · Cited by 17
“Olakanmi et al. (2000) reported that gallium nitrate and gallium transferrin were effective against Mycobacterium tuberculosis and Mycobacterium avium complex, including those organisms living within human macrophages.”
BackgroundInfluentialGugala, N., Chatfield-Reed, K., Turner, R., & Chua, G. (2019) · Genes · doi:10.3390/genes10010034 · Cited by 16
“As a result, this metal is approved by the US Food and Drug Administration for the treatment of cancer-associated hypercalcemia (Ganite®, Genta, NJ, USA) and has been tested as an antimicrobial agent against a variety of organisms including Mycobacterium tuberculosis [15,16], Pseudomonas aeruginosa [9,10,17], Staphylo…”
BackgroundKeenan, T., Placek, L., Coughlan, A., Bowers, G., Hall, M., & Wren, A. (2016) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2016.07.100 · Cited by 16
A Review of the Development of Multitarget Molecules against HIV-TB Coinfection Pathogens
Leite, D. I., Moura, S. D. C. B., da Conceição, A. D. M., Costa, C. C. P., Machado, G. P., Pimentel, L., Branco, F., Moreira, R., Bastos, M., & Boechat, N. (2023) · Molecules · doi:10.3390/molecules28083342 · Cited by 15
Utilization of Fe3+-acinetoferrin analogs as an iron source by Mycobacterium tuberculosis
Rodriguez, G. M., Gardner, R. A., Kaur, N., & Phanstiel, O. (2008) · Biometals · doi:10.1007/s10534-007-9096-5 · Cited by 15
“tuberculosis and is toxic to this bacterium probably because it can substitute for Fe and disrupt many cellular processes (Olakanmi et al. 2000).”
BackgroundV, N., Anand, T., Singh, C. K., & Sodhi, K. K. (2024) · Journal of Organometallic Chemistry · doi:10.1016/j.jorganchem.2024.123389 · Cited by 14
Gallium maltolate: safety in neonatal foals following multiple enteral administrations.
Martens, R., Cohen, N. D., Fajt, V., Nerren, J., Chaffin, M., Taylor, R. J., & Bernstein, L. R. (2010) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/j.1365-2885.2009.01121.x · Cited by 14
“Gallium, a trivalent semi-metal that shares many chemical similarities with Fe3+ and functions as a ferric iron mimic, has been used to control various microorganisms by exploiting their iron dependency (Bernstein, 1998; Oyebode et al., 2000; Harrington et al., 2006; Kaneko et al., 2007).”
BackgroundRepurposing nonantibiotic drugs as antibacterials
Thakare, R., Kaul, G., Shukla, M., Kesharwani, P., Srinivas, N., Dasgupta, A., & Chopra, S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818480-6.00005-9 · Cited by 14
Evaluation of in vitro toxicity of hydroxyapatite doped with gallium
Melnikov, P., Matos, M. D. F. C., Malzac, A., Teixeira, A. R., & de Albuquerque, D. M. (2019) · Materials letters (General ed.) · doi:10.1016/j.matlet.2019.06.095 · Cited by 13
Stealing Survival: Iron Acquisition Strategies of Mycobacterium tuberculosis.
Shankar, G., & Akhter, Y. (2024) · Biochimie · doi:10.1016/j.biochi.2024.06.006 · Cited by 12
Gleeson, L. E., & Waterer, G. (2022) · Breathe · doi:10.1183/20734735.0171-2021 · Cited by 11
Wang, Q., Lv, H., Ding, F., Jin, Z.-Y., Liu, Y.-H., Sun, X., Ye, L., Xu, W., Mu, C.-F., Shen, J.-L., et al. (2021) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2021.130346 · Cited by 11
Rule-based modelling of iron homeostasis in tuberculosis.
Ghosh, S., Prasad, K. S., Vishveshwara, S., & Chandra, N. (2011) · Molecular Biosystems · doi:10.1039/c1mb05093a · Cited by 11
Guirado, E., Arcos, J., Knaup, R., Reeder, R., Betz, B., Cotton, C., Patel, T., Pfaller, S., Torrelles, J., & Schlesinger, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045411 · Cited by 10
“To Assess Intracellular Growth, MDM-infected Monolayers were Washed and Either Repleted with RH Containing 1% Human Autologous Serum and Further Incubated for 48 to 96 h or directly lysed (2 h time-point) as we previously described [32].”
Self-citationKeiser, T., Azad, A., Guirado, E., Bonacci, R. A., & Schlesinger, L. (2011) · Infection and Immunity · doi:10.1128/iai.05635-11 · Cited by 10
“20% autologous serum, allowing a total of 12 days of growth (19).”
BackgroundSelf-citationFecteau, M., Fyock, T., Mcadams, S., Boston, R., Whitlock, R., & Sweeney, R. (2011) · American Journal of Veterinary Research · doi:10.2460/ajvr.72.9.1243 · Cited by 10
Evaluation of the effect of gallium maltolate on fecal Salmonella shedding in cattle.
Nerren, J., Edrington, T., Bernstein, L. R., Farrow, R., Genovese, K., Callaway, T. R., Anderson, R., Krueger, N., Duke, S. E., & Nisbet, D. J. (2011) · Journal of Food Protection · doi:10.4315/0362-028x.jfp-10-298 · Cited by 10
Krauße‐Opatz, B., Wittkop, U., Gutzki, F. M., Schmidt, C., Jürgens‐Saathoff, B., Meier, S., Beckmann, B., Takikawa, O., Morgan, M. A., Tsikas, D., et al. (2009) · Microbial Pathogenesis · doi:10.1016/j.micpath.2009.03.001 · Cited by 9
Olmo-Fontánez, A. M., Scordo, J. M., Schami, A., Garcia-Vilanova, A., Pino, P. A., Hicks, A., Mishra, R., Maselli, D. J., Peters, J., Restrepo, B. I., et al. (2024) · Mucosal Immunology · doi:10.1016/j.mucimm.2024.01.001 · Cited by 9
“For determination of intracellular M.tb by the CFUs method, infected ATs at MOI 10:1 were lysed and enumerated as described previously 11,59 .”
MethodSelf-citationBeyond antibiotics for pulmonary nontuberculous mycobacterial disease.
Waterer, G. (2020) · Current opinion in pulmonary medicine · doi:10.1097/mcp.0000000000000665 · Cited by 9
“avium resident inside macrophages, in part as gallium is concentrated in the intracellular space of phagocytes [66].”
BackgroundTaudte, N., German, N., Zhu, Y.-G., Grass, G., & Rensing, C. (2016) · Biometals · doi:10.1007/s10534-016-9927-3 · Cited by 9
“Generally, it was observed that iron-limitation promotes gallium-toxicity (Beriault et al. 2007; Kaneko et al. 2007; Olakanmi et al. 2000) and this was also the case for the iron/manganese-uptake mutant characterized in this study.”
BackgroundVitamin Deficiency and Tuberculosis: Need for Urgent Clinical Trial for Managment of Tuberculosis
Banerjee, D. (2014) · Journal of Nutritional Health & Food Science · doi:10.15226/jnhfs.2014.00118 · Cited by 11
“Iron is essentially needed by Mycobacterium tuberculosis for almost all of its strategies for successful intracellular survival and pathogenecity in human hosts, including the activity of enzymes against oxidative burst, supply of oxygen to hypoxic atmosphere by mycobacterial truncated haemoglobins, arresting phagosom…”
BackgroundSong, T., Zhao, X.-L., Shao, Y., Guo, M., Li, C.-H., & Zhang, W.-W. (2019) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1903.03008 · Cited by 8
The Biofilm Formation onto Implants and Prosthetic Materials May Be Contrasted Using Gallium (3+)
Rimondini, L., Valle, C. D., Cochis, A., Azzimonti, B., & Chiesa, R. (2013) · doi:10.4028/www.scientific.net/kem.587.315 · Cited by 8
“The property of Ga 3+ to mimic and replace iron is called “Trojan horse” strategy [14] and can be exploited to disrupt iron metabolism in a wide range of bacteria, including mycobacteria [16], Pseudomonas aeruginosa [14], methicillin-resistant S.”
BackgroundSturm, B., Lassacher, U., Ternes, N., Jallitsch, A., Goldenberg, H., & Scheiber-Mojdehkar, B. (2006) · Biochimie · doi:10.1016/j.biochi.2005.12.001 · Cited by 8
Schami, A., Islam, M. N., Wall, M., Hicks, A., Meredith, R., Kreiswirth, B. N., Mathema, B., Belisle, J. T., & Torrelles, J. B. (2024) · Scientific Reports · doi:10.1038/s41598-024-81457-0 · Cited by 7
“Similarly, hMDM monolayers in wells were infected with a MOI of 1:1 to determine intracellular growth at 2, 24, 72, and 120 h post-infection (hpi) using the CFU method as described 42,47 .”
Emerging and alternative strategies for the treatment of nontuberculous mycobacterial infections
Sreekumar, A., Kumar, A., Biswas, R., & Biswas, L. (2024) · Expert Review of Anti-Infective Therapy · doi:10.1080/14787210.2024.2395003 · Cited by 7
“…iron metabolism, thereby hindering the growth of mycobacteria such as M. tuberculosis , M. avium , and M. abscessus , highlighting its therapeutic potential [136,137] These findings underscore the potential of small molecules in developing effective and specific therapies for NTM infections.”
Song, P.-C., Wu, T., Hong, M., & Chen, M. (2015) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2015.05.005 · Cited by 11
The potential of drug repurposing to face bacterial and fungal biofilm infections
Oliveira, I. M., Borges, A. D. S., & Simões, M. V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819497-3.00014-3 · Cited by 6
Old biomarkers in tuberculosis management: are they still useful? a systematic review
Fusani, L., Tersigni, C., Chiappini, E., Venturini, E., & Galli, L. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1898945 · Cited by 6
Keenan, T., Placek, L., Keenan, N. L., Hall, M., & Wren, A. W. (2016) · Journal of Biomaterials Applications · doi:10.1177/0885328216646655 · Cited by 6
Ball, K. R., Sampieri, F., Chirino, M., Hamilton, D. L., Blyth, R. I. R., Sham, T., Dowling, P. M., & Thompson, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00616-13 · Cited by 7
“The mean tissue concentration in this study exceeds the concentrations required to inhibit growth of Pseudomonas aeruginosa and Mycobacterium tuberculosis in vitro, suggesting that oral administration of gallium maltolate can produce potentially clinically relevant gallium concentrations in homogenized bladder tissue…”
BackgroundDenis, M., & Buddle, B. M. (2005) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2005.04.010 · Cited by 5
Gallium and Gallium Semiconductor Compounds
Fowler, B., & Sexton, M. (2015) · doi:10.1016/b978-0-444-59453-2.00036-6 · Cited by 6
Iron Chelation in Chemotherapy
Weinberg, E. D. (2003) · Advances in applied microbiology · doi:10.1016/s0065-2164(03)01008-6 · Cited by 7
Pollina, G. F., Pepe, M., Dean, A., Marco, V. D., & Marton, D. (2013) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12022 · Cited by 5
Coordination and Solution Chemistry of the Metals: Biological, Medical and Environmental Relevance
Brothers, P. J., & Ruggiero, C. E. (2011) · Wiley eBooks · doi:10.1002/9780470976548.ch9 · Cited by 7
Lechuga-Ballesteros, D., Truong-Le, V., & Patzer, E. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp086 · Cited by 5
Moore, J., Murphy, A., Millar, B., Loughrey, A., Rooney, P., Elborn, J., & Goldsmith, C. (2009) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2008.09.018 · Cited by 5
Plant-based siderophore: a new avenue in molecular medicine for tuberculosis.
Dam, T., & Babu, C. R. (2003) · Journal of Medical Microbiology · doi:10.1099/jmm.0.05144-0 · Cited by 5
“In vitro growth studies using standard culture media indicate that siderophore-mediated iron acquisition plays a critical role in growth and metabolism of M. tuberculosis (Olakanmi et al., 2000).”
BackgroundEvaluation of serum iron and iron binding capacity in cows with paratuberculosis
Senturk, S., Metcitoglu, Z., Ülgen, M., Borum, E., Temizel, E., & Kasap, S. (2009) · Tierärztliche Praxis G: Großtiere/Nutztiere · doi:10.1055/s-0038-1623829 · Cited by 5
Ilchenko, O., Nikolaevskaya, E., Zinchenko, O., Ivanytsia, V., Prat-Aymerich, C., Ramstedt, M., & Rzhepishevska, O. (2024) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1474071 · Cited by 4
Akhter, A., Moliva, J. I., Azad, A. K., Olmo-Fontánez, A. M., Garcia-Vilanova, A., Scordo, J. M., Gavrilin, M., Diaz, P. T., Endsley, J., Weintraub, S. T., et al. (2023) · bioRxiv · doi:10.1101/2023.10.01.560171 · Cited by 4
“Authors declare no conflict of interest.”
Self-citationMonk, C., Sweeney, R., Bernstein, L., & Fecteau, M. (2016) · American Journal of Veterinary Research · doi:10.2460/ajvr.77.2.151 · Cited by 4
Efficacy of gallium maltolate against Lawsonia intracellularis infection in a rabbit model.
Sampieri, F., Allen, A., Alcorn, J., Clark, C., Vannucci, F., Pusterla, N., Mapes, S., Ball, K. R., Dowling, P. M., Thompson, J., et al. (2014) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12132 · Cited by 4
“Thus, at sufficiently high concentrations, GaIII can be absorbed by bacteria, altering the first step of the bacterial ferric metabolism (Olakanmi et al., 2000).”
BackgroundBagire, P. G., Ogwang, P., Lusi, J. K., Lusi, J. P., Daddy, N. B., Kahatwa, S., Serugendo, A., & Kihemba, K. (2022) · Pharmacy & Pharmacology International Journal · doi:10.15406/ppij.2022.10.00379 · Cited by 3
Bj, S., Sohal, J., Stephen, B. J., Jain, M., Dhama, K., Sv, S., Singh, S. V., Datta, M., Jain, N., Jayaraman, S., et al. (2015) · Asian Journal of Animal and Veterinary Advances · doi:10.3923/ajava.2015.830.842 · Cited by 3
Pharmacokinetics of gallium maltolate in Lawsonia intracellularis-infected and uninfected rabbits.
Sampieri, F., Alcorn, J., Allen, A., Clark, C., Vannucci, F., Pusterla, N., Mapes, S., Ball, K. R., Dowling, P. M., Thompson, J., et al. (2014) · Journal of Veterinary Pharmacology and Therapeutics · doi:10.1111/jvp.12114 · Cited by 3
Relating pH and Ion Release from Ga2O3-Na2O-CaO-ZnO-SiO2 Bioactive Glasses
Keenan, T., Wren, A., Coughlan, A., Towler, M., & Hall, M. (2013) · 2013 39th Annual Northeast Bioengineering Conference · doi:10.1109/nebec.2013.133 · Cited by 3
“Ga is included in these glasses because it has exhibited anti-bacterial properties [1], and anticancer abilities [2].”
BackgroundAljabri, M. D., El-Bahy, S. M., El-Sayed, R., Debbabi, K. F., Amin, A. S., & Mohamed, N. M. (2024) · Sensing and Bio-Sensing Research · doi:10.1016/j.sbsr.2024.100687 · Cited by 2
GALLIUM NANOPARTICLES AS DELIVERY SYSTEM AGAINST INFECTIOUS DISEASES AND CANCER
Mandal, A. (2020) · doi:10.36106/ijar/7012037 · Cited by 2
Na, H., Kim, Y., Kim, D., Yoon, H., & Ryu, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.02397 · Cited by 2
Unraveling Resistance Mechanisms against New Antimicrobials Using Transposon Mutagenesis
García‐Contreras, R. (2013) · Cloning & Transgenesis · doi:10.4172/2168-9849.1000115 · Cited by 2
“aeruginosa [44], and has antibacterial effects on other important human pathogens, such as Mycobacterium tuberculosis [45] and multi-drug resistant strains of Acinetobacter baumanii [46].”
BackgroundMain-Group Medicinal Chemistry Including Li and Bi
Seng, H.-L., & Tiekink, E. R. T. (2013) · Comprehensive Inorganic Chemistry II · doi:10.1016/b978-0-08-097774-4.00338-7 · Cited by 1
The structural characterization of Ga2O3-Na2O-CaO-ZnO-SiO2 bioactive glasses
Keenan, T., Wren, A., Coughlan, A., Hall, M., & Towler, M. (2012) · Northeast Bioengineering Conference · doi:10.1109/nebc.2012.6207114 · Cited by 1
“Gallium was chosen because it has exhibited properties such as the ability to lower blood-calcium levels [3], inhibit bacterial growth [4], and also because it has exhibited anticancer abilities [5].”
BackgroundGramolini, L., López-Corbalán, R., García-Millán, J., Kircheva, N., Marazzi, M., & García‐Iriepa, C. (2026) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.6c02504
Arnett, E., Lumbreras, M., Hernandez, E., Campos, D., Wager, C. M. L., Pahari, S., Matouba, D., Determann, B. F., Renshaw, C., Longstreet, B., et al. (2026) · iScience · doi:10.1016/j.isci.2026.116276
Self-citationRosa, M. D., Vaccarella, E., Cerasti, F., Lucchesi, V., Marini, F., Massimi, L., Mastrantonio, V., Sciubba, F., Spagnoli, M., Porretta, D., et al. (2026) · Environmental Pollution · doi:10.1016/j.envpol.2026.127661
Placek, L., Perry, D. L., Towler, M., & Wren, A. W. (2025) · Applied Sciences · doi:10.3390/app15147756
Retinoic Acid and Iron Metabolism: A Step Towards Design of a Novel Antitubercular Drug
Chakraborty, S., Bhattacharyya, R., Sayal, K., & Banerjee, D. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201015666141126121639 · Cited by 2
“[53] Olakanmi, O.”
Background
Metadata
- Authors
- Olakanmi, O., Britigan, B. E., & Schlesinger, L. S.
- Affiliations
- United States Department of Veterans Affairs (US)
- University of Iowa (US)
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2000-10
- Volume
- 68
- Issue
- 10
- Pages
- 5619-5627
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- PMC
- PMC101514
- OpenAlex
- W2161032017
- Cited by
- 220
- References
- 57
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 12 · 2023: 13 · 2022: 10 · 2021: 7 · 2020: 11 · 2019: 13 · 2018: 7 · 2017: 9 · 2016: 16 · 2015: 8 · 2014: 10 · 2013: 15 · 2012: 8
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Infection and Immunity (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health (AI24954, 5r01hl051990-05, AI43870, AI33004)
- National Heart, Lung, and Blood Institute (HL-51990)
- National Cancer Institute
- National Institute of Allergy and Infectious Diseases (AI 33004, AI 24954)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Keywords
- gallium, iron acquisition, siderophores, Mycobacterium tuberculosis, Mycobacterium avium complex, macrophages, phagosome, intracellular mycobacteria, iron metabolism, bactericidal activity, gallium nitrate, intracellular survival
- MeSH terms
- Cells, Cultured, Culture Media, Gallium, Humans, Iron, Macrophages, Microscopy, Electron, Scanning, Monocytes, Mycobacterium tuberculosis, Transferrin, Mycobacterium avium Complex, Macrophages, Alveolar
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review